miRNA: A Promising Therapeutic Target in Cancer

Int J Mol Sci. 2022 Sep 29;23(19):11502. doi: 10.3390/ijms231911502.

Abstract

microRNAs are small non-coding RNAs that regulate several genes post-transcriptionally by complementarity pairing. Since discovery, they have been reported to be involved in a variety of biological functions and pathologies including cancer. In cancer, they can act as a tumor suppressor or oncomiR depending on the cell type. Studies have shown that miRNA-based therapy, either by inhibiting an oncomiR or by inducing a tumor suppressor, is effective in cancer treatment. This review focusses on the role of miRNA in cancer, therapeutic approaches with miRNAs and how they can be effectively delivered into a system. We have also summarized the patents and clinical trials in progress for miRNA therapy.

Keywords: cancer; miRNA; miRNA delivery; oncomiR; therapy; tumor suppressor.

Publication types

  • Review

MeSH terms

  • Gene Expression Regulation, Neoplastic
  • Genes, Tumor Suppressor
  • Humans
  • MicroRNAs* / genetics
  • Neoplasms* / genetics
  • Neoplasms* / pathology
  • Neoplasms* / therapy

Substances

  • MicroRNAs

Grants and funding

This research received no external funding.